Advertisement

Annals of Surgical Oncology

, Volume 22, Issue 10, pp 3191–3196 | Cite as

The Ethics of Breast Surgery

  • Alyssa Throckmorton
  • Lindi VanderWalde
  • Craig Brackett
  • Laura Dominici
  • Thomas Eisenhauer
  • Nathalie Johnson
  • Amanda Kong
  • Kandice Ludwig
  • Jennifer O’Neill
  • Matthew Pugliese
  • Paige Teller
  • Terry Sarantou
Breast Oncology

Abstract

Breast surgery has evolved as a subspecialty of general surgery and requires a working knowledge of benign and malignant diseases, surgical techniques, shared decision-making with patients, collaboration with a multi-disciplinary team, and a basic foundation in surgical ethics. Ethics is defined as the practice of analyzing, evaluating, and promoting best conduct based upon available standards. As new information is obtained or as cultural values change, best conduct may be re-defined. In 2014, the Ethics Committee of the ASBrS acknowledged numerous ethical issues, specific to the practice of breast surgery. This independent review of ethical concerns was created by the Ethics Committee to provide a resource for ASBrS members as well as other surgeons who perform breast surgery. In this review, the professional, clinical, research and technology considerations that breast surgeons face are reviewed with guidelines for ethical physician behavior.

Keywords

National Comprehensive Cancer Network National Comprehensive Cancer Network Ethic Consultation Ethical Duty Certified Genetic Counselor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Andersson GB, Chapman JR, Dekutoski MB, et al. Do no harm: the balance of “beneficence” and “non-maleficence.” Spine. 2010;35(suppl 9):S2–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Rosenthal, Angelos P, Cooper DS, et al. Clinical and professional ethics guidelines for the practice of thyroidology. Thyroid. 2013;23:1203–10.Google Scholar
  3. 3.
    Rosenthal MS. Ethical issues in the management of thyroid disease. Endocrinol Metab Clin North Am. 2014;43:545–64.CrossRefPubMedGoogle Scholar
  4. 4.
    University of Ottawa medical curriculum: Basic Ethical Principles. Basic Concepts in Medical Ethics page. Society, the Individual, and Medicine website. http://www.med.uottawa.ca/sim/data/Ethics_e.htm. Accessed 1 Dec 2014.
  5. 5.
    McCormick TR. Principles of bioethics. [University of Washington School of Medicine Department of Bioethics & Humanities Ethics in Medicine website, Bioethics Tools] 2013 (last modified October 1, 2013). https://depts.washington.edu/bioethx/tools/princpl.html. Accessed 1 Dec 2014.
  6. 6.
    Adedeji S, Sokol DK, Palser T, McKneally M. Ethics of surgical complications. World J Surg. 2009;33:732–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Loewenstein G. Projection bias in medical decision making. Med Decision Making. 2005;25:96–105.CrossRefGoogle Scholar
  8. 8.
    Langstein HN, Cheng MH, Singletary SE, et al. Breast cancer recurrence after immediate reconstruction: patterns and significance. Plast Reconstr Surg. 2003;111;712–20.CrossRefPubMedGoogle Scholar
  9. 9.
    Kroll SS, Schusterman MA, Tadjalli HE, Singletary SE, Ames FC. Risk of recurrence after treatment of early breast cancer with skin-sparing mastectomy. Ann Surg Oncol. 1997;4:193–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Foster RD, Esserman LJ, Anthony JP, Hwang ES, Do H. Skin sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma. Ann Surg Oncol. 2002;9:462–6.CrossRefPubMedGoogle Scholar
  11. 11.
    National Accreditation Program for Breast Centers. NAPBC Standards Manual. 2014 ed. Chicago: American College of Surgeons; 2014. https://www.facs.org/~/media/files/quality%20programs/napbc/2014%20napbc%20standards%20manual.ashx. Accessed 15 May 2015.
  12. 12.
    Moyer VA, U.S. Preventive Services Task Force. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:271–81.PubMedGoogle Scholar
  13. 13.
    The Genetic Information Nondiscrimination Act of 2008. http://www.eeoc.gov/laws/statutes/gina.cfm. Accessed 20 May 2015.
  14. 14.
    Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol. 2006;24:700–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Surbone A. Social and ethical implications of BRCA testing. Ann Oncol. 2011;22:160–6.CrossRefGoogle Scholar
  16. 16.
    Irwin B, Peppercorn J. Promise and perils of guidelines in quality cancer care. J Oncol Pract. 2012;8:354–7.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    American Society of Breast Surgeons Consensus Statement on Accelerated Partial Breast Irradiation. 2011. https://www.breastsurgeons.org/new_layout/about/statements/index.php. Accessed 15 May 2015.
  18. 18.
    Smith B, Arthur DW, Buchholz TA. Accelerated Partial Breast Irradiation Consensus Statement from American Society for Radiation Oncology (ASTRO). Int J Rad Oncol Biol Phys. 2009;74:987–1001.CrossRefGoogle Scholar
  19. 19.
    Shah C, Vicini F, Wazer DE, Arthur D, Patel RR. The American Brachytherapy Society consensus statement for accelerated partial breast irradiation. Brachytherapy. 2013;12:267–77.CrossRefPubMedGoogle Scholar
  20. 20.
    Thuerlimann B, Koeberle D, Senn H. Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations. Eur J Cancer. 2007;43:46–52.CrossRefPubMedGoogle Scholar
  21. 21.
    Verma S, Trudeau M. Canadian oncologists attitudes towards guideline development and outcomes of clinical trials based on results of the ATAC trial [abstract]. Proceedings of the 26th Annual San Antonio Breast Cancer Symposium. December 3–6; 2003. Abstract 657.Google Scholar
  22. 22.
    Palazzi M, De Tomasi D, D’Affronto C, et al. Are international guidelines for the prescription of adjuvant treatment for early breast cancer followed in clinical practice? Results of a population based study on 1547 patients. Tumori. 2002;88:503–6.PubMedGoogle Scholar
  23. 23.
    Roila F, Ballatori E, Patoia L, et al. Drug utilization review team in oncology. Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy. Ann Oncol. 2003;14:843–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Hebert-Croteau N, Brisson J, Latreille J, et al. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol. 2004;22:3685–93.CrossRefPubMedGoogle Scholar
  25. 25.
    Bloom BS, de Pouvourville N, Chhatre S, Jayadevappa R, Weinberg D. Breast cancer treatment in clinical practices compared to best evidence and practice guidelines. Br J Cancer. 2004;90:26–30.PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Landercasper J, Dietrich LL, Johnson JM. A breast center review of compliance with National Comprehensive Cancer Network Breast Cancer guidelines. Am J Surg. 2006;192:526–7.CrossRefGoogle Scholar
  27. 27.
    Wu X-C, Lund MJ, Kimmick GG, et al. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol. 2012;30:142–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Lim T, Marin D. The assessment of decisional capacity. Neuro Clin. 2011;29:115–26.CrossRefGoogle Scholar
  29. 29.
    Sessums LL, Zembrzuska H, Jackson JL. Does this patient have medical decision-making capacity? JAMA. 2011;306:420–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Brendel RW, Wei MH, Schouten R, Edersheim JG. An approach to selected legal issues: confidentiality, mandatory reporting, abuse and neglect, informed consent, capacity decisions, boundary issues, and malpractice claims. Med Clinic NA. 2010;94:1229–40.CrossRefGoogle Scholar
  31. 31.
    Paterick T, Carson G, Allen M, et al. Medical informed consent: general considerations for physicians. Mayo Clin Proc. 2008;83:313–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Emanuel E. A review of the ethical and legal aspects of terminating medical care. Am J Med. 1988;84:291–301.CrossRefPubMedGoogle Scholar
  33. 33.
    Braddock CH III. Do different standards apply to withholding and withdrawing care? Termination of Life-Sustaining Treatment. [University of Washington School of Medicine Department of Bioethics & Humanities Ethics in Medicine website, Bioethics Topics]. 1998 (last modified April 6, 2009). https://depts.washington.edu/bioethx/topics/termlife.html#vs. Accessed 8 May 2015.
  34. 34.
    Ackerman RJ. Withholding and withdrawing life-sustaining treatment. Am Fam Phys. 2000;62:1555–60.Google Scholar
  35. 35.
    National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Bethesda, MD: US Government Printing Office; 1978. http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html. Accessed 15 May 2015.
  36. 36.
    McDonald PJ, Kulkarni AV, Farrokhyar F, Bhandari M. Ethical issues in surgical research. Can J Surg. 2010;53:133–6.PubMedCentralPubMedGoogle Scholar
  37. 37.
    Transparency reports and reporting of physician ownership or investment interests. Social Security Act. Section 1128G. http://www.ssa.gov/OP_Home/ssact/title11/1128G.htm. Accessed 20 May 2015.
  38. 38.
    Angelos P. Surgical ethics and the challenge of surgical innovation. Am J Surg. 2014;208(6):881–5.CrossRefPubMedGoogle Scholar
  39. 39.
    Shore R, Halsey J, Shah K, et al. Report of the AMA council on ethical and judicial affairs: report on professionalism and use of social media. J Clin Ethics. 2011;22:165–72.PubMedGoogle Scholar
  40. 40.
    Professionalism in the use of social media. Code of Medical Ethics of the American Medical Association [e-book]. 2014–15 edn. American Medical Association, Chicago. Sec 9.124:641–848.Google Scholar
  41. 41.
    Shay D. Physician use of social media: navigating the risk. Med Econ. 2014;25:44–6.Google Scholar

Copyright information

© Society of Surgical Oncology 2015

Authors and Affiliations

  • Alyssa Throckmorton
    • 1
    • 2
  • Lindi VanderWalde
    • 1
  • Craig Brackett
    • 3
  • Laura Dominici
    • 4
  • Thomas Eisenhauer
    • 5
  • Nathalie Johnson
    • 6
  • Amanda Kong
    • 7
  • Kandice Ludwig
    • 8
  • Jennifer O’Neill
    • 9
  • Matthew Pugliese
    • 10
  • Paige Teller
    • 11
  • Terry Sarantou
    • 12
  1. 1.Baptist Cancer CenterMemphisUSA
  2. 2.University of TennesseeMemphisUSA
  3. 3.Coastal Carolina Breast CenterMurrells InletUSA
  4. 4.Dana Farber/Brigham and Women’s Cancer CenterBostonUSA
  5. 5.University of North CarolinaChapel HillUSA
  6. 6.Legacy Cancer InstitutePortlandUSA
  7. 7.Medical College of WisconsinMilwaukeeUSA
  8. 8.Indiana UniversityIndianapolisUSA
  9. 9.Arizona Associated SurgeonsPhoenixUSA
  10. 10.University HospitalAugustaUSA
  11. 11.Atirus Health - Harvard Vanguard Medical AssociatesBostonUSA
  12. 12.Department of General Surgery, Levine Cancer InstituteCarolinas HealthCare SystemCharlotteUSA

Personalised recommendations